Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Govoni

Showing results (21-30 of 127) with videos related to

Pageof 13
Sort By:
Vox Sanguinis|January 1, 1991
Occurrence of platelet satellitism in blood donorsM Govoni, G L Lodi, C Menini
Reumatismo|November 24, 2021
Herpes zoster infection following mRNA COVID-19 vaccine in a patient with ankylosing spondylitisB Maranini, G Ciancio, R Cultrera, et al.
Lupus|October 6, 2016
Application of SLICC classification criteria in undifferentiated connective tissue disease and evolution in systemic lupus erythematosus: analysis of a large monocentric cohort with a long-term follow-upA Bortoluzzi, F Furini, F Campanaro, et al.
Vox Sanguinis|January 1, 1990
Rifampicin-induced immune hemolytic anemia: therapeutic relevance of plasma exchangeM Govoni, M Moretti, C Menini, et al.
Reumatismo|May 4, 2022
Reply to: "Herpes zoster seven days after SARS-CoV-2 vaccination in a patient with ankylosing spondylitis under adalimumab" by Josef FinstererB Maranini, G Ciancio, R Cultrera, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Persistence Rate With Subcutaneous Biologic Therapies in Patients With Rheumatoid Arthritis (Ra)R Lyu, Q Ding, M Govoni, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Treatment Persistence With Subcutaneous Biologic Therapies in Patients With Psoriatic Arthritis (Psa)R Lyu, Q Ding, M Govoni, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Persistence Rate With Subcutaneous Biologic Therapies in Patients With Ankylosing Spondylitis (As)M Govoni, R Lyu, Q Ding, et al.
Experimental Cell Research|March 1, 1994
Inhibition of topoisomerase II activity and its effect on nucleolar structure and functionM Govoni, F Farabegoli, A Pession, et al.
Immunohematology|September 18, 2004
Anti-cE (Rh27), a rarely occurring antibodyG Lodi, D Resca, R Reverberi, et al.
Pageof 13

Showing results (21-30 of 127) with videos related to

Sort By:
Pageof 13
Vox Sanguinis|January 1, 1991
Occurrence of platelet satellitism in blood donorsM Govoni, G L Lodi, C Menini
Reumatismo|November 24, 2021
Herpes zoster infection following mRNA COVID-19 vaccine in a patient with ankylosing spondylitisB Maranini, G Ciancio, R Cultrera, et al.
Lupus|October 6, 2016
Application of SLICC classification criteria in undifferentiated connective tissue disease and evolution in systemic lupus erythematosus: analysis of a large monocentric cohort with a long-term follow-upA Bortoluzzi, F Furini, F Campanaro, et al.
Vox Sanguinis|January 1, 1990
Rifampicin-induced immune hemolytic anemia: therapeutic relevance of plasma exchangeM Govoni, M Moretti, C Menini, et al.
Reumatismo|May 4, 2022
Reply to: "Herpes zoster seven days after SARS-CoV-2 vaccination in a patient with ankylosing spondylitis under adalimumab" by Josef FinstererB Maranini, G Ciancio, R Cultrera, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Persistence Rate With Subcutaneous Biologic Therapies in Patients With Rheumatoid Arthritis (Ra)R Lyu, Q Ding, M Govoni, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Treatment Persistence With Subcutaneous Biologic Therapies in Patients With Psoriatic Arthritis (Psa)R Lyu, Q Ding, M Govoni, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Persistence Rate With Subcutaneous Biologic Therapies in Patients With Ankylosing Spondylitis (As)M Govoni, R Lyu, Q Ding, et al.
Experimental Cell Research|March 1, 1994
Inhibition of topoisomerase II activity and its effect on nucleolar structure and functionM Govoni, F Farabegoli, A Pession, et al.
Immunohematology|September 18, 2004
Anti-cE (Rh27), a rarely occurring antibodyG Lodi, D Resca, R Reverberi, et al.
Pageof 13